Stocks and Investing
Stocks and Investing
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Catherine Ramsey Maintained (TWST) at Buy with Decreased Target to $18 on, May 8th, 2023
Catherine Ramsey of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $29 to $18 on, May 8th, 2023.
Catherine has made no other calls on TWST in the last 4 months.
There is 1 other peer that has a rating on TWST. Out of the 1 peers that are also analyzing TWST, all agrees with Catherine's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Sykes of "Goldman Sachs" Maintained at Hold with Decreased Target to $20 on, Wednesday, April 19th, 2023
Contributing Sources